What You Should Know:
- Wavemaker Three-Sixty Health (Wavemaker 360), the nation’s leading venture fund focused on early-stage (primarily seed) healthcare disruptors and innovators, recently announced its Fund II news, closing at $64M, surpassing its first fund nearly four times over.
- The goal for Fund II is to invest into 40-50 early-stage companies, with several investments already made into some of the most compelling healthcare start-ups in the areas of health-tech, digital health,
Read More
Startups| Digital Health | | Health IT News, Analysis, Insights - HIT Consultant
Invoca Raises $83M to Optimize Contact Center Experience
What You Should Know:
- Invoca, the cloud leader in AI-powered conversation intelligence for revenue teams" has raised $83M in its Series F at a $1.1B valuation led by
- With 6 of the top 10 U.S. health systems, 3 of the top 8 U.S. physical therapy clinics, and 4 of the top 6 U.S. dental service organizations already using Invoca, this recent round of funding will help improve the contact center experience for healthcare organizations.
Addressing Healthcare Staffing
Read More
Capital Rx Raises $106M to End Drug Price Distortion
What You Should Know:
- Capital Rx, a health technology company changing the way prescription drugs are priced and patients are serviced raises $106M in a Series C round to end drug price distortion. The Series C round was led by B Capital with participation from General Catalyst and existing investors, Transformation Capital and Edison Partners, bringing the total amount raised to $175M.
- Capital Rx will continue to invest in the technology backbone for claims processing and benefit
Read More
H1 Adds $20M to Series C to Power Democratization of Global Healthcare Data
What You Should Know:
- H1, the connecting force for global healthcare professional, clinical, science, and research information, announced their Series C extension led by Goldman Sachs Asset Management, Menlo Ventures, Transformation Capital and Novartis Pharma AG, bringing the total Series C raise to over $120M.
- The news comes at a time when public markets are down and many other companies are doing down rounds. The extension allows H1’s valuation of $773M to stay constant,
Read More
Nava Benefits Nabs $40M to Bring F500 Healthcare Benefits Downstream
Bicycle Health Secures $50M for Virtual Opioid Use Disorder Treatment
What You Should Know:
Bicycle Health, a Boston, MA-based provider of virtual opioid addiction treatment raises $50M in Series B funding led by InterAlpen Partners, bringing the company’s total funds raised to $83 million. Other participants in the round include existing investors Questa Capital, Frist Cressey Ventures, and City Light Capital.
Evidence-based, online suboxone treatment for opioid addiction
Founded in 2017, Bicycle Health provides confidential, convenient and
Read More
L7 Informatics Raises $38M to Digitalize Precision Healthcare
What You Should Know:
- L7 Informatics, a leader in software for life sciences that delivers a flexible end-to-end platform for precision healthcare, today announced a $38M investment led by Banneker Partners with participation from its pre-existing investors.
- The company will use the new funding to accelerate product development, expand L7|ESP's global reach, and build on L7's outstanding customer support.
Precision healthcare offers significant improvements in
Read More
Anthem Partners With Happify Health to Enhance Maternal Health
What You Should Know:
- Anthem, Inc. today announced a collaboration between Happify Health to bridge the gap between the unique physical and mental health concerns women face.
- The collaboration will add to its ongoing support of the whole health of women with the addition of a new a digital-first solution in select markets.
Enhance Maternal Health with New Digital-First Solution
It is part of Anthem’s early and consistent support of women throughout the entirety of their maternal
Read More
Insilico Medicine Raises $60M, Launches AI-powered Drug Discovery Robotics Laboratory
What You Should Know:
- Insilico Medicine, an NYC-based clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company raises $60 million in Series D financing from a syndicate of global investors with expertise in investing in the biopharmaceutical and life sciences sectors.
- Insilico is also launching a new state-of-the-art robotics lab and fully robotic biological data factory. They have seen a string of successes thus far in 2022, including the
Read More
Watchmaker Genomics Raises $40M to Expand Clinical Sequencing Product Offerings
What You Should Know:
- Watchmaker Genomics, a life sciences company specializing in the development of high-stringency applications focused on the reading, writing, and editing of DNA and RNA raises $40M in an oversubscribed Series A, bringing total funding to date to $53.5M. The round was led by Decheng Capital, with co-investment from Eclipse Ventures.
- Watchmaker Genomics applies advanced enzymology to enable breakthrough applications for the reading, writing, and
Read More
